Skip to content

Clinical trials

Philadelphia Chromosome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Philadelphia Chromosome Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20131
20151
20171
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University2
Bristol-Myers Squibb1
Chinese Academy of Medical Sciences1
Institute of Hematology & Blood Diseases Hospital, China1
Novartis Pharmaceuticals1
Pfizer1
The First Affiliated Hospital of Soochow University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Philadelphia Chromosome8
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Leukemia2
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Acute1
Neoplasm, Residual1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.